Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wheat polar lipid complex (WPLC) is a standardized dietary supplement ingredient derived from wheat, primarily composed of sphingolipids (ceramides) and digalactosyl diglycerides (DGDG). Marketed under the brand name Ceramosides, it is designed to enhance skin and hair health through oral supplementation. The complex works by replenishing essential lipids in the stratum corneum, thereby improving skin hydration, elasticity, and barrier function, and reducing signs of aging such as wrinkles. In hair care, WPLC has been shown to reduce hair shedding and promote growth by modulating the hair cycle, specifically increasing the anagen-to-telogen ratio. It is also being investigated for its potential to alleviate vaginal dryness in postmenopausal women. WPLC is available in both oil and powder forms for inclusion in various supplement formats.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wheat polar lipid complex.